c-Fgr Monoclonal Antibody

This gene is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to plasma membrane ruffles, and functions as a negative regulator of cell migration and adhesion triggered by the beta-2 integrin signal transduction pathway. Infection with Epstein-Barr virus results in the overexpression of this gene. Multiple alternatively spliced variants, encoding the same protein, have been identified.

Introducing the C-FGR Monoclonal Antibody, a cutting-edge biotechnological product designed to revolutionize the field of immunology. This meticulously crafted antibody is derived from a single clone, ensuring utmost purity and consistency in its performance.

The C-FGR Monoclonal Antibody exhibits exceptional specificity towards the FGR protein, a key regulator of cellular signaling pathways. Through its targeted binding, this antibody effectively neutralizes FGR activity, thereby offering a novel approach to modulating cellular responses and potentially mitigating various pathological conditions.

Crafted with utmost precision, the C-FGR Monoclonal Antibody boasts an impressive affinity for its target, enabling robust and reliable detection and quantification of FGR protein levels. Its exceptional sensitivity allows for accurate monitoring of FGR expression dynamics, facilitating comprehensive research and diagnostic applications.

Furthermore, the C-FGR Monoclonal Antibody's exceptional stability and long shelf life ensure consistent performance and reliability, making it an indispensable tool for laboratories and research institutions alike. Its compatibility with various experimental techniques, including immunohistochemistry, Western blotting, and flow cytometry, further enhances its versatility and applicability across diverse scientific disciplines.

In summary, the C-FGR Monoclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, sensitivity, and stability. With its potential to unravel novel insights into cellular signaling pathways and its broad range of applications, this antibody is poised to redefine the boundaries of scientific discovery.